Autobio Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	798.41	592.27	465.37	1,486	1,138	769.4
Short-Term Investments	-	-	3,574	2,333	3,141	3,000
Trading Asset Securities	185.18	502.1	3.61	700.57	-	7.34
Cash & Short-Term Investments	983.59	1,094	4,043	4,521	4,278	3,777
Cash Growth	112.04%	-72.93%	-10.57%	5.66%	13.27%	7.75%
Accounts Receivable	1,139	1,195	1,177	1,181	1,074	1,003
Other Receivables	31.27	21.96	110.74	24.25	34.86	31.69
Receivables	1,170	1,217	1,288	1,206	1,109	1,035
Inventory	938.24	935.45	1,153	778.29	752.3	589.34
Other Current Assets	3,002	3,061	59.25	108.54	113.63	156.62
Total Current Assets	6,093	6,308	6,543	6,613	6,254	5,558
Property, Plant & Equipment	3,803	3,865	3,982	3,883	3,293	2,864
Long-Term Investments	271.88	178.63	172.54	123.31	13.76	1.72
Goodwill	164.65	164.65	164.65	164.65	164.65	164.65
Other Intangible Assets	187.19	168.14	136.09	179.03	203.27	227.85
Long-Term Deferred Tax Assets	356.68	349.2	335.66	274.61	238.73	201.76
Long-Term Deferred Charges	294.02	275	382.71	179.23	169.97	137.11
Other Long-Term Assets	1,071	981.08	158.7	137.55	135.59	78.07
Total Assets	12,242	12,290	11,875	11,554	10,472	9,233
Accounts Payable	1,369	1,522	1,135	726.15	1,010	355.24
Accrued Expenses	107.64	281.5	349.51	364.54	335.93	238.07
Short-Term Debt	51.29	38.34	240.21	353.28	113.84	121.39
Current Portion of Long-Term Debt	10.32	10.5	285	342	-	100.08
Current Portion of Leases	-	-	8.34	10.93	12.56	9.78
Current Income Taxes Payable	148.83	169.08	102.38	137.85	86.48	77.62
Current Unearned Revenue	113.26	120.09	166.11	148.14	135.48	125.1
Other Current Liabilities	478.01	488	372.71	400.25	472.27	431.28
Total Current Liabilities	2,278	2,629	2,660	2,483	2,167	1,459
Long-Term Leases	7.09	10.28	20.63	24.64	16.26	26.16
Long-Term Unearned Revenue	84.82	66.82	214.65	118.98	101.77	75.68
Long-Term Deferred Tax Liabilities	241.28	246.73	284.19	258.03	273.03	269.1
Other Long-Term Liabilities	375.68	320.36	4.25	2.92	2.22	-
Total Liabilities	2,987	3,273	3,183	2,888	2,560	1,829
Common Stock	571.42	571.42	581.01	586.27	586.27	586.27
Additional Paid-In Capital	3,329	3,329	3,819	4,101	4,101	4,101
Retained Earnings	5,261	5,024	4,676	4,091	3,338	2,590
Treasury Stock	-	-	-461.03	-243.3	-243.3	-
Comprehensive Income & Other	0.78	0.94	1.14	1.03	0.61	-0.07
Total Common Equity	9,162	8,926	8,617	8,535	7,783	7,277
Minority Interest	92.78	90.09	75.27	130.87	129.59	126.49
Shareholders' Equity	9,255	9,016	8,692	8,666	7,912	7,403
Total Liabilities & Equity	12,242	12,290	11,875	11,554	10,472	9,233
Total Debt	68.69	59.12	554.19	730.85	142.66	257.4
Net Cash (Debt)	914.9	1,035	3,488	3,790	4,136	3,520
Net Cash Growth	718.61%	-70.32%	-7.95%	-8.37%	17.50%	6.70%
Net Cash Per Share	1.60	1.81	6.05	6.54	7.08	6.00
Filing Date Shares Outstanding	576.7	565.5	576.91	581.01	581.01	586.27
Total Common Shares Outstanding	576.7	565.5	576.91	581.01	581.01	586.27
Working Capital	3,815	3,679	3,883	4,130	4,087	4,099
Book Value Per Share	15.89	15.78	14.94	14.69	13.39	12.41
Tangible Book Value	8,811	8,593	8,316	8,192	7,415	6,884
Tangible Book Value Per Share	15.28	15.20	14.41	14.10	12.76	11.74
Buildings	-	-	1,895	1,152	829.25	473.02
Machinery	-	-	2,916	2,740	2,492	2,283
Construction In Progress	-	-	987.28	1,591	1,272	1,105

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.